Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: a proof of concept study
- PMID: 27083159
- PMCID: PMC5052311
- DOI: 10.1007/s00405-016-4038-x
Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: a proof of concept study
Abstract
Disease specific patterns of volatile organic compounds can be detected in exhaled breath using an electronic nose (e-nose). The aim of this study is to explore whether an e-nose can differentiate between head and neck, and lung carcinoma. Eighty-seven patients received an e-nose measurement before any oncologic treatment. We used PARAFAC/TUCKER3 tensor decomposition for data reduction and an artificial neural network for analysis to obtain binary results; either diagnosed as head and neck or lung carcinoma. Via a leave-one-out method, cross-validation of the data was performed. In differentiating head and neck from lung carcinoma patients, a diagnostic accuracy of 93 % was found. After cross-validation of the data, this resulted in a diagnostic accuracy of 85 %. There seems to be a potential for e-nose as a diagnostic tool in HNC and lung carcinoma. With a fair diagnostic accuracy, an e-nose can differentiate between the two tumor entities.
Keywords: Diagnosis; Electronic nose; Head and neck carcinoma; Lung carcinoma; Volatile organic compounds.
Conflict of interest statement
The authors of this study did not and will not receive any financial support of companies, associations or organizations. The authors have no other conflicts of interest. Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent Informed consent was obtained from all individual participants included in the study.
Figures
References
-
- Hirsch FR, Franklin WA, Gazdar AF, Bunn PA., Jr Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001;7(1):5–22. - PubMed
-
- Willis CM, Britton LE, Harris R, Wallace J, Guest CM. Volatile organic compounds as biomarkers of bladder cancer: sensitivity and specificity using trained sniffer dogs. Cancer Biomark. 2010;8(3):145–153. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
